Cardiomyocyte‐specific MC1R deficiency attenuates physiological and pathological cardiac hypertrophy in mice, while pharmacological activation of MC1R promotes cardiomyocyte hypertrophy. This evidence concerns the gene MC1R and cardiac hypertrophy.